close
Add to watchlist
Bioanalytical Systems, Inc (BASI) Healthcare, Biotechnology & Drugs
Bioanalytical Systems, Inc. provides contract development services and research equipment to pharmaceutical, medical research, and biotechnology companies and institutions worldwide. The company operates in two segments, Research Services and Research Products. The Research Services segment provides various services, including screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets robotic sampling systems and accessories, including disposables, training, and systems qualification; in vivo microdialysis collection systems; physiology monitoring tools; and liquid chromatography and electrochemistry instrument platforms. Its product portfolio includes the Culex APS, a robotic automated pharmacology system; bioanalytical separation systems to detect and quantify low concentrations of substances; specialized chemical analyzers that monitor trace levels of organic chemicals; epsilon, a single liquid chromatography and electrochemistry instrument control platform; a line of miniaturized in vivo sampling devices sold to drug developers and medical research centers that assist in the study of various medical conditions including stroke, depression, Alzheimer's and Parkinson's diseases, diabetes, and osteoporosis; and Vetronics, animal diagnostic electro-cardiogram and vital signs monitors used in veterinary clinics. The company also manufactures scientific instruments for medical research, which it sells with related software for use in industrial, governmental, and academic laboratories. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 1.20 |
| Volume | 19509 |
| Volume Avg | 17777 |
| 52 Week High | 2.89 |
| 52 Week Low | 1.10 |
| PE | N/A |
| PE (group average) | 39 |
| EPS Year | -0.89 |
| EPS change Q/Q | -1000% |
| EPS change Q/Q Yr ago | -1000% |
| EPS change Q/Q next Q est | -14.29% |
| EPS change Y/Y | -473.68% |
| REV change Q/Q | 9.46% |
| REV change Q/Q Yr ago | 26.56% |
| EPS next Q est | 0.07 |
| EPS next Y est | 0.36 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |